Financhill
Back

Bright Minds Biosciences Quote, Financials, Valuation and Earnings

Bright Minds Biosciences Price Quote

$43.34
-0.66 (10.62%)
(Updated: November 30, 2024 at 5:30 AM ET)

Bright Minds Biosciences Key Stats

Sell
25
Bright Minds Biosciences (DRUG) is a Sell

Day range:
$39.24 - $45.39
52-week range:
$0.93 - $79.02
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
44.11%

Volume:
210.3K
Avg. volume:
1.7M
1-year change:
3135.29%
Market cap:
$196.4M
Revenue:
$0
EPS:
$-0.68

How Much Does Bright Minds Biosciences Make?

Data Unavailable

Is Bright Minds Biosciences Growing As A Company?

Data Unavailable

Bright Minds Biosciences Stock Price Performance

What Is Bright Minds Biosciences 52-Week High & Low?

Bright Minds Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bright Minds Biosciences?

Is Bright Minds Biosciences Cash Flow Positive?

  • What Is DRUG Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.9M
  • What Is Bright Minds Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $588K
  • What Is Bright Minds Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bright Minds Biosciences Return On Invested Capital

Data Unavailable

Bright Minds Biosciences Earnings Date & Stock Price

Bright Minds Biosciences Competitors

Bright Minds Biosciences Dividend Yield

Bright Minds Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many DRUG shares are owned by institutional investors?
    2.4M DRUG shares are owned by institutional investors
  • How many DRUG shares are owned by insiders?
    0 DRUG shares are owned by insiders